Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2181-2190

  Thomas, Susan N ^a   Rutkowski, Joseph M ^a   Pasquier, Miriella ^a   Kuan, Emma L ^b   Alitalo, Kari ^c   Randolph, Gwendalyn J ^b,d   Swartz, Melody A ^a  

^a EPFL   (Switzerland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 4; OVALBUMIN; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSPORT; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPH VESSEL; LYMPHATIC DRAINAGE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; CELL MIGRATION INHIBITION; DENDRITIC CELLS; DERMIS; DRAINAGE; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; LYMPH NODES; LYMPHATIC ABNORMALITIES; LYMPHATIC VESSELS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84865424661     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103545     Document Type: Article

References (63)

1. Friedlaender, M. H., and H. Baer. 1972. Immunologic tolerance: role of the regional lymph node. Science 176: 312-314.
2. Friedlaender, M. H., F. V. Chisari, and H. Baer. 1973. The role of the inflammatory response of skin and lymph nodes in the induction of sensitization to simple chemicals. J. Immunol. 111: 164-170.
3. Hintzen, G., L. Ohl, M. L. del Rio, J. I. Rodriguez-Barbosa, O. Pabst, J. R. Kocks, J. Krege, S. Hardtke, and R. Förster. 2006. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J. Immunol. 177: 7346-7354.
4. Reynoso, E. D., J. W. Lee, and S. J. Turley. 2009. Peripheral tolerance induction by lymph node stroma. In Crossroads between Innate and Adaptive Immunity II. S. P. Schoenberger, P. D. Katsikis, and B. Pulendran, eds. Springer, New York, p. 113-127.
5. Baird, J. B., J. L. Charles, T. G. Streit, J. M. Roberts, D. G. Addiss, and P. J. Lammie. 2002. Reactivity to bacterial, fungal, and parasite antigens in patients with lymphedema and elephantiasis. Am. J. Trop. Med. Hyg. 66: 163-169.
6. von der Weid, P. Y., S. Rehal, and J. G. P. Ferraz. 2011. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27: 335-341.
7. Angeli, V., F. Ginhoux, J. Llodrà, L. Quemeneur, P. S. Frenette, M. Skobe, R. Jessberger, M. Merad, and G. J. Randolph. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24: 203-215.
8. Halin, C., N. E. Tobler, B. Vigl, L. F. Brown, and M. Detmar. 2007. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110: 3158-3167.
9. Yin, N., N. Zhang, J. N. Xu, Q. X. Shi, Y. Z. Ding, and J. S. Bromberg. 2011. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation 92: 25-30.
10. Kerjaschki, D., H. M. Regele, I. Moosberger, K. Nagy-Bojarski, B. Watschinger, A. Soleiman, P. Birner, S. Krieger, A. Hovorka, G. Silberhumer, et al. 2004. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15: 603-612.
11. Ling, S., C. Qi, W. Li, J. Xu, and W. Kuang. 2009. Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed. Clin. Experiment. Ophthalmol. 37: 874-883.
12. Dietrich, T., F. Bock, D. Yuen, D. Hos, B. O. Bachmann, G. Zahn, S. Wiegand, L. Chen, and C. Cursiefen. 2010. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J. Immunol. 184: 535-539.
13. Hoffmann, F., E. P. Zhang, A. Mueller, F. Schulte, H. D. Foss, J. Franke, and S. E. Coupland. 2001. Contribution of lymphatic drainage system in corneal allograft rejection in mice. Graefes Arch. Clin. Exp. Ophthalmol. 239: 850-858.
14. Kerjaschki, D. 2006. Lymphatic neoangiogenesis in renal transplants: a driving force of chronic rejection? J. Nephrol. 19: 403-406.
15. Huggenberger, R., S. S. Siddiqui, D. Brander, S. Ullmann, K. Zimmermann, M. Antsiferova, S. Werner, K. Alitalo, and M. Detmar. 2011. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117: 4667-4678.
16. Stuht, S., W. Gwinner, I. Franz, A. Schwarz, D. Jonigk, H. Kreipe, D. Kerjaschki, H. Haller, and M. Mengel. 2007. Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies. Am. J. Transplant. 7: 377-384.
17. Harrell, M. I., B. M. Iritani, and A. Ruddell. 2007. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 170: 774-786.
18. Ruddell, A., M. I. Harrell, and M. Furuya. 2009. Sentinel lymph node lymphangiogenesis and increased lymph flow in murine tumor metastasis. Clin. Exp. Metastasis 26: 883-884.
19. Lund, A. W., F. V. Duraes, S. H. Hirosue, V. R. Raghavan, C. Nembrini, S. N. Thomas, A. Issa, S. Hugues, and M. A. Swartz. 2012. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Reports 1: 191-199.
20. Swartz, M. A., and A. W. Lund. 2012. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat. Rev. Cancer 12: 210-219.
21. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5: 617-628.
22. Junt, T., E. A. Moseman, M. Iannacone, S. Massberg, P. A. Lang, M. Boes, K. Fink, S. E. Henrickson, D. M. Shayakhmetov, N. C. Di Paolo, et al. 2007. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450: 110-114.
23. Roozendaal, R., T. R. Mempel, L. A. Pitcher, S. F. Gonzalez, A. Verschoor, R. E. Mebius, U. H. von Andrian, and M. C. Carroll. 2009. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity 30: 264-276.
24. Itano, A. A., and M. K. Jenkins. 2003. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4: 733-739.
25. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371.
26. Mueller, S. N., and R. N. Germain. 2009. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat. Rev. Immunol. 9: 618-629.
27. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
28. Mori, S., H. Nakano, K. Aritomi, C. R. Wang, M. D. Gunn, and T. Kakiuchi. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193: 207-218.
29. Davalos-Misslitz, A. C., J. Rieckenberg, S. Willenzon, T. Worbs, E. Kremmer, G. Bernhardt, and R. Förster. 2007. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur. J. Immunol. 37: 613-622.
30. Nitta, T., S. Nitta, Y. Lei, M. Lipp, and Y. Takahama. 2009. CCR7-mediated migration of developing thymocytes to the medulla is essential for negative selection to tissue-restricted antigens. Proc. Natl. Acad. Sci. USA 106: 17129-17133.
31. + regulatory T cells. J. Exp. Med. 204: 735-745.
32. Menning, A., U. E. Höpken, K. Siegmund, M. Lipp, A. Hamann, and J. Huehn. 2007. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur. J. Immunol. 37: 1575-1583.
33. + regulatory T cells. J. Immunol. 174: 6993-7005.
34. Lee, J. W., M. Epardaud, J. Sun, J. E. Becker, A. C. Cheng, A. R. Yonekura, J. K. Heath, and S. J. Turley. 2007. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8: 181-190.
35. Cohen, J. N., C. J. Guidi, E. F. Tewalt, H. Qiao, S. J. Rouhani, A. Ruddell, A. G. Farr, K. S. Tung, and V. H. Engelhard. 2010. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207: 681-688.
36. Mäkinen, T., L. Jussila, T. Veikkola, T. Karpanen, M. I. Kettunen, K. J. Pulkkanen, R. Kauppinen, D. G. Jackson, H. Kubo, S. Nishikawa, et al. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7: 199-205.
37. Rutkowski, J. M., C. E. Markhus, C. C. Gyenge, K. Alitalo, H. Wiig, and M. A. Swartz. 2010. Dermal collagen and lipid deposition correlate with tissue swelling and hydraulic conductivity in murine primary lymphedema. Am. J. Pathol. 176: 1122-1129.
38. Swartz, M. A., A. Kaipainen, P. A. Netti, C. Brekken, Y. Boucher, A. J. Grodzinsky, and R. K. Jain. 1999. Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J. Biomech. 32: 1297-1307.
39. Lämmermann, T., B. L. Bader, S. J. Monkley, T. Worbs, R. Wedlich-Söldner, K. Hirsch, M. Keller, R. Förster, D. R. Critchley, R. Fässler, and M. Sixt. 2008. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453: 51-55.
40. Swartz, M. A., D. A. Berk, and R. K. Jain. 1996. Transport in lymphatic capillaries. I. Macroscopic measurements using residence time distribution theory. Am. J. Physiol. 270: H324-H329.
41. Bajénoff, M., J. G. Egen, L. Y. Koo, J. P. Laugier, F. Brau, N. Glaichenhaus, and R. N. Germain. 2006. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25: 989-1001.
42. -) TCR αβ splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. PLoS One 5: e11427.
43. Saito, E., M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T. F. Tedder, and S. Sato. 2002. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109: 1453-1462.
44. Sato, S., M. Hasegawa, M. Fujimoto, T. F. Tedder, and K. Takehara. 2000. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165: 6635-6643.
45. + T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168: 3079-3087.
46. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790.
47. Chu, V. T., A. Beller, T. T. Nguyen, G. Steinhauser, and C. Berek. 2011. The long-term survival of plasma cells. Scand. J. Immunol. 73: 508-511.
48. Hofmann, J., M. Greter, L. Du Pasquier, and B. Becher. 2010. B-cells need a proper house, whereas T-cells are happy in a cave: the dependence of lymphocytes on secondary lymphoid tissues during evolution. Trends Immunol. 31: 144-153.
49. Schröder, A. E., A. Greiner, C. Seyfert, and C. Berek. 1996. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93: 221-225.
50. Stott, D. I., F. Hiepe, M. Hummel, G. Steinhauser, and C. Berek. 1998. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J. Clin. Invest. 102: 938-946.
51. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12: 117-139.
52. Sugaya, M., Y. Kuwano, H. Suga, T. Miyagaki, H. Ohmatsu, T. Kadono, H. Okochi, A. Blauvelt, K. Tamaki, and S. Sato. 2012. Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. J. Invest. Dermatol. 132: 667-676.
53. Sugaya, M., T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al. 2005. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood 105: 2356-2363.
54. Greter, M., J. Hofmann, and B. Becher. 2009. Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol. 7: e1000109.
55. Chen, L., P. Hamrah, C. Cursiefen, Q. Zhang, B. Pytowski, J. W. Streilein, and M. R. Dana. 2004. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat. Med. 10: 813-815.
56. Hamrah, P., L. Chen, Q. Zhang, and M. R. Dana. 2003. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am. J. Pathol. 163: 57-68.
57. Tsuji, R. F., M. Szczepanik, I. Kawikova, V. Paliwal, R. A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L. A. Herzenberg, and P.W. Askenase. 2002. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196: 1277-1290.
58. Watanabe, R., M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki. 2007. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am. J. Pathol. 171: 560-570.
59. Mebius, R. E., P. R. Streeter, J. Brevé, A. M. Duijvestijn, and G. Kraal. 1991. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J. Cell Biol. 115: 85-95.
60. Tomei, A. A., S. Siegert, M. R. Britschgi, S. A. Luther, and M. A. Swartz. 2009. Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J. Immunol. 183: 4273-4283.
61. Wengner, A. M., U. E. Höpken, P. K. Petrow, S. Hartmann, U. Schurigt, R. Bräuer, and M. Lipp. 2007. CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. Arthritis Rheum. 56: 3271-3283.
62. Tomura, M., T. Honda, H. Tanizaki, A. Otsuka, G. Egawa, Y. Tokura, H. Waldmann, S. Hori, J. G. Cyster, T. Watanabe, et al. 2010. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120: 883-893.
63. Kodera, T., T. L. McGaha, R. Phelps, W. E. Paul, and C. A. Bona. 2002. Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-b production by fibroblasts. Proc. Natl. Acad. Sci. USA 99: 3800-3805.